ZRANB1 and neoplasm: By treating mice with vehicle control and PARP inhibitor, we demonstrated that olaparib significantly inhibited tumor growth of TRABID WT-expressing tumors compared with EV control and TRABID-C443S-expressing tumors (Fig. 6g, h).